Global Malaria Programme
The WHO Global Malaria Programme (GMP) is responsible for coordinating WHO's global efforts to control and eliminate malaria. Its work is guided by the "Global technical strategy for malaria 2016–2030" adopted by the World Health Assembly in May 2015 and updated in 2021.
Highlights
/global-malaria-programme-(gmp)/office-of-the-director-(mdo)/gmp-annual-report-2024.jpg?sfvrsn=f2cd5db0_6 "gmp-annual-report-2024")
Publications
All →
14 September 2022
Malaria vaccines: preferred product characteristics and clinical development considerations
"Preferred product characteristics” (PPCs) are key tools to incentivize and guide the development of urgently needed health products. The PPCs published...
6 May 2022
WHO working group on late-stage development for malaria vaccines to reduce disease burden
On 12 and 19 April 2021, a WHO working group on late-stage development of malaria vaccines to reduce disease burden was convened by the WHO Department...
10 February 2022
Malaria Vaccine Advisory Committee (MALVAC) meeting on Preferred Product Characteristics for malaria...
On 27–28 October 2020, the WHO Initiative for Vaccine Research and Global Malaria Programme convened a meeting of the Malaria Vaccine Advisory Committee...
Ways to access malaria guidance
Clear, evidence-informed WHO recommendations are designed to guide countries as they develop national malaria strategic plans; they support decisions around “what to do”.
/in-page-highlights/malaria-magicapp-square.png?sfvrsn=5377a7ae_23 "malaria-magicapp-square")
/in-page-highlights/malaria-toolkit-app-square_e84ff510-2b45-4bcf-97a7-ac89aadf011d.jpg?sfvrsn=bbe7d3f2_23 "malaria-toolkit-app-square")
/in-page-highlights/illustration-for-new-guidance.jpg?sfvrsn=396b72fa_3 "illustration-for-new-guidance")
/mme-images/mme-banner-small.jpg?sfvrsn=84d5cea_4 "mme-banner-small")
/malaria-vaccine-first-babies-500pix7b68b5bd00bf49a79517fea854f4cbf3_3becb335-06a4-43af-9b5b-56ef8683aef8.jpg?sfvrsn=41bda56f_25 "malaria-vaccine-first-babies-500pix")